Daiichi Sankyo and AstraZeneca’s ENHERTU showed an objective response rate of 37.1% in the overall population of the DESTINY-PanTumor02 phase 2 trial...
Leading Global Provider of Pharmaceutical and Medical Solutions to the Maritime Industry Establishes Distribution Center in Top Hub for International Shipping Integrates...
Industry veteran and senior medical leader from Pfizer brings deep global expertise as Vaxxas advances multiple clinical programs and moves toward commercialization....
Encouraging interim results from Phase 1 human clinical trial show COVID-19 vaccine candidate, called HexaPro, to be safe and well tolerated with...
SEOUL, South Korea–(BUSINESS WIRE)–#BIOInternationalConvention—Basgenbio Inc., a clinico-genomic cohort data-based R&D company, has announced that the company will be presenting at the BIO...
Basic engineering of Vast’s 30MW VS1 Port Augusta CSP Project to be completed by July with groundbreaking slated for 2024 SYDNEY, Australia–(BUSINESS...
Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis who have...
New list highlights companies recognized globally for employee sentiment and satisfaction SPARTANBURG, S.C.–(BUSINESS WIRE)–Milliken & Company is a part of the first...
– Novel seed treatment brings next-level sustainability in pest control while promoting healthy plant establishment – Contains best-in-class PLINAZOLIN® technology BASEL, Switzerland–(BUSINESS...
SHANGHAI–(BUSINESS WIRE)–AntChain announced a new collaboration with Intel to launch AntChain Massive Data Privacy-Preserving Computing Platform (MAPPIC), a new privacy-preserving computing (PPC)...